Updates are available Erratum dated 2021-07-01
Click to view Erratum: https://doi.org/10.1007/s13311-021-01148-w
-
Authors
-
Funding
Funding for this research was provided by:
Heinrich-Heine-Universität Düsseldorf
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-021-01102-w
CrossRef DOI link to the associated document: https://doi.org/10.1007/s13311-021-01148-w
Content Type: article
Copyright: Copyright © 2021 The authors. Published by Elsevier B.V. All rights reserved.
